Sarcoid-Like Granulomatosis Induced by Nivolumab Treatment in a Lung Cancer Patient

Nivolumab, an anti-PD-1 antibody, inhibits binding between PD-1 and PD-1 ligand and activates antigen-specific T cells that have become unresponsive to cancer cells. Although it is recommended as a second-line therapy in gene mutation-negative non-small-cell lung cancer, interstitial pneumonia is a...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Susumu Noguchi, Hiroaki Kawachi, Hiroshi Yoshida, Akari Fukao, Satoshi Terashita, Tatsuyoshi Ikeue, Sadao Horikawa, Takakazu Sugita
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Karger Publishers 2018-08-01
Цуврал:	Case Reports in Oncology
Нөхцлүүд:	Nivolumab Sarcoid-like granulomatosis Lung cancer Pleomorphic carcinoma
Онлайн хандалт:	https://www.karger.com/Article/FullText/492383
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!